CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $817K of Corcept Therapeutics Incorporated
Sold$817,334
$40.87Price
20,000Shares
−94%Stake
What CORT did after the filing
- The stock from Fri, Feb 6 open, $39.01
- −13.8%
- S&P 500, same days
- −3.8%
Measured over 30 trading days, to the Mar 23 close.
Traded Tue, Feb 3. Filed Thu, Feb 5, 5:42 PM ET, after the close. Returns use the Feb 6 open and the Mar 23 close. Not investment advice.